BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CCND3, P30281, 896, ENSG00000112576
46 results:

  • 1. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
    Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
    Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast cancer in China.
    Zhong X; Chen P; He P; Wu Y; Suo J; Zhu K; Yan X; Tian T; Yang Q; Luo T
    Clin Breast Cancer; 2024 Feb; 24(2):e41-e50. PubMed ID: 37865566
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of performance between O-RADS, IOTA simple rules risk assessment and ADNEX model in the discrimination of ovarian Brenner tumors.
    Shang J; Lei T; Wu L; Lin M; Xie H
    Arch Gynecol Obstet; 2023 Sep; 308(3):961-970. PubMed ID: 37186266
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
    Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
    J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
    Talhouk A; Jamieson A; Crosbie EJ; Taylor A; Chiu D; Leung S; Grube M; Kommoss S; Gilks CB; McAlpine JN; Singh N
    Int J Gynecol Pathol; 2023 Jul; 42(4):353-363. PubMed ID: 36731023
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
    Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
    Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric cancer.
    Song J; Wei R; Huo S; Gao J; Liu X
    Front Immunol; 2022; 13():920512. PubMed ID: 35769483
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia.
    Sait KH; Alam MZ; Haque A; Sait HK; Sait MK; Anfinan NM
    Saudi Med J; 2022 Feb; 43(2):146-155. PubMed ID: 35110339
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer.
    Lerner-Geva L; Chetrit A; Farhi A; Lubin F; Sadezki S;
    Arch Gynecol Obstet; 2022 Jul; 306(1):209-217. PubMed ID: 35039881
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association of IL-6 -174G>C and -572G>C Polymorphisms with Susceptibility to Cervical cancer and ovarian cancer.
    Hashemzehi A; Karimi-Zarchi M; Parsaeian SF; Asadian F; Golestanpour H; Setayesh S; Shaker SA; Zare-Shehneh M; Neamatzadeh H
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2867-2871. PubMed ID: 34582655
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
    Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
    Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
    Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.
    Shen Y; Gao L; Jiang S; Liu J; Cheng W; Shou H
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):70-75. PubMed ID: 33629514
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of Aspirin Use With cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and ovarian cancer Screening Trial.
    Loomans-Kropp HA; Pinsky P; Umar A
    JAMA Netw Open; 2021 Jan; 4(1):e2032072. PubMed ID: 33449095
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses.
    Guo Y; Jiang T; Ouyang L; Li X; He W; Zhang Z; Shen H; You Z; Yang G; Lai H
    Gynecol Oncol; 2021 Mar; 160(3):704-712. PubMed ID: 33357959
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial ovarian Tumors.
    Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
    Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. External validation of Risk of Malignancy Index compared to IOTA Simple Rules.
    Mulder EE; Gelderblom ME; Schoot D; Vergeldt TF; Nijssen DL; Piek JM
    Acta Radiol; 2021 May; 62(5):673-678. PubMed ID: 32567319
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A 3-Tier Chemotherapy Response Score for ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant?
    Lawson BC; Euscher ED; Bassett RL; Liu J; Ramalingam P; Zhong Y; Fleming ND; Malpica A
    Am J Surg Pathol; 2020 Feb; 44(2):206-213. PubMed ID: 31651523
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
    Gentry-Maharaj A; Burnell M; Dilley J; Ryan A; Karpinskyj C; Gunu R; Mallett S; Deeks J; Campbell S; Jacobs I; Sundar S; Menon U
    Am J Obstet Gynecol; 2020 Jan; 222(1):56.e1-56.e17. PubMed ID: 31351062
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.